Stephen West Appointed to Coiled Therapeutics Board
1 report, 1 independent
Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Stephen West has been appointed as a Non-Executive Director of Coiled Therapeutics plc. The company, which is listed on AIM under the ticker COIL, is a clinical-stage precision oncology company developing small molecule therapies for various cancers.
From investegate.co.uk
Why it matters
Coiled Therapeutics focuses on generating evidence for its lead programme, AO-252, which is currently in a Phase I clinical trial in the U.S. The appointment adds to the company's governance structure as it advances its pipeline.
Coiled Therapeutics is a company whose business involves the development of small molecule therapies for genetically defined cancers.
From investegate.co.uk
Who's involved
- Stephen WestAppointed Non-Executive Director of Coiled Therapeutics